Toggle light / dark theme

Immunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when it’s combined with chemotherapy, a new clinical trial reports.

Those who got immunotherapy before and after surgery — along with pre-surgical chemo — had a 42% lower risk of cancer progression, recurrence or death than those who only received chemo, according to findings published Wednesday in the New England Journal of Medicine.

Further, about 25% of those who got immunotherapy and chemo had no cancer at all remaining after their surgery, compared with about 5% of those who got chemo alone.

SPECULOOS-3 b is practically the same size as our planet,” said Dr. Michaël Gillon. “A year, i.e. an orbit around the star, lasts around 17 hours. Days and nights, on the other hand, should never end.


What types of exoplanets can dwarf stars possess? This is what a recent study published in Nature Astronomy hopes to address as a team of international researchers announced the discovery of SPECULOOS 3 b, which is an Earth-sized exoplanet located approximately 55 light-years from Earth orbiting an ultra-cool dwarf star. What makes this study unique is astronomers know very little about dwarf stars and the exoplanets that could potentially orbit them, despite the number of dwarf stars outnumbering Sun-like stars throughout the cosmos. This study holds the potential to help astronomers better understand the formation and evolution of exoplanets around smaller stars and what the implications for finding life beyond Earth.

“SPECULOOS-3 b is practically the same size as our planet,” said Dr. Michaël Gillon, who is a professor at the University of Liège and first author of the study. “A year, i.e. an orbit around the star, lasts around 17 hours. Days and nights, on the other hand, should never end. We believe that the planet rotates synchronously, so that the same side, called the day side, always faces the star, just like the Moon does for the Earth. On the other hand, the night side hand, would be locked in endless darkness.”

Quest users searching the Store will now be able to more easily find games published through its early access distribution channel, App Lab, which previously weren’t visible, effectively giving smaller studios a more level playing field.

Meta is making its operating system and app store available on third-party VR headsets sometime soon, and one of the bigger changes coming to the platform is the blurring of the barrier between the Main Store and App Lab.

Besides offering a way for studios to publish their titles in early access, App Lab also lets any developer who meets basic technical and content requirements ship software on the platform, effectively making it open to studios of any size.